RWMG
SYRS

Redwood Wealth Management Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Redwood Wealth Management Group’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,157
Closed -$5.97K – 1164
2024
Q2 		$5.97K Buy
+1,157
New +$5.97K ﹤0.01% 703